Does Risk of Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?

[1]  I. Nagtegaal,et al.  Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Gavin,et al.  ‘Missed’ oesophageal adenocarcinoma and high-grade dysplasia in Barrett’s oesophagus patients: A large population-based study , 2018, United European gastroenterology journal.

[3]  Matthew Banks,et al.  Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) , 2017, Gut.

[4]  H. El‐Serag,et al.  The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett’s Esophagus , 2017, The American Journal of Gastroenterology.

[5]  Kenneth K Wang,et al.  Persistence of Nondysplastic Barrett’s Esophagus Is Not Protective Against Progression to Adenocarcinoma , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  I. Nagtegaal,et al.  535 Incidence of Malignant Progression in Persistent Nondysplastic Barrett's Esophagus, a Dutch Nationwide Cohort Study , 2017 .

[7]  P. Martinez,et al.  Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus , 2016, Nature Communications.

[8]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[9]  S. Menon,et al.  How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis , 2014, Endoscopy International Open.

[10]  D. Whiteman,et al.  Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus. , 2014, Gastrointestinal endoscopy.

[11]  A. Gavin,et al.  Symptoms and Endoscopic Features at Barrett's Esophagus Diagnosis: Implications for Neoplastic Progression Risk , 2013, The American Journal of Gastroenterology.

[12]  Carissa A. Sanchez,et al.  Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus , 2013, Cancer Prevention Research.

[13]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[14]  Prateek Sharma,et al.  Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. , 2013, Gastroenterology.

[15]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[16]  A. Gavin,et al.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.

[17]  A. Gavin,et al.  Increasing incidence of Barrett’s oesophagus: a population-based study , 2011, European Journal of Epidemiology.

[18]  J. Barendregt,et al.  Is endoscopic surveillance for non‐dysplastic Barrett's esophagus cost‐effective? Review of economic evaluations , 2011, Journal of gastroenterology and hepatology.

[19]  M. Coleman,et al.  Guidelines on confidentiality for population-based cancer registration , 2005, Asian Pacific journal of cancer prevention : APJCP.